Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Neoplasms 6Brain Neoplasms 5Prostatic Neoplasms 3Radiation Injuries 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm Metastasis 2Hemangioma 2Carcinoma, Non-Small-Cell Lung 2Scleroderma, Localized 1Radiation Pneumonitis 1Popliteal Cyst 1Polycystic Ovary Syndrome 1Optic Neuritis 1Neurodermatitis 1Neoplastic Cells, Circulating 1Neoplasms, Fibrous Tissue 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasms by Histologic Type 1Nasopharyngeal Carcinoma 1Myelitis, Transverse 1Myelitis 1Musculoskeletal Diseases 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Lung Diseases, Interstitial 1

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × Adrenal Cortex Hormones × Clear all
NCT03050866 2021-08-20

CABA-V7

Erasmus Medical Center

Phase 2 Unknown
140 enrolled
Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT01393730 2018-03-15

Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
40 enrolled 12 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00006371 2012-09-27

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
2 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡